Search Details

Word: mullens (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

...Terriers took the lead minutes later, when Brad Zancanaro, standing right in front of Gibson, deflected in a point shot from Mark Mullen. The Huskies answered before the end of the first to tie the score...

Author: By Timothy M. Mcdonald, SPECIAL TO THE CRIMSON | Title: Danis Withstands Flurry of Shots To Down M. Hockey | 1/26/2004 | See Source »

...Brendan Mullen is an analyst with the Washington, D.C.-based Council of International Hospitals, a division of The Advisory Board Company...

Author: By J. BRENDAN Mullen, | Title: Osama's Real Endgame | 10/10/2003 | See Source »

...This is something Heinz realized when it made Dinner Doctors on Britain's Channel 5. The campaign built around the cooking show, including a website and supermarket promotions, cost about $3 million and "was a better way to optimize our spend than traditional advertising," says Heinz spokesman Michael Mullen. In line with Britain's strict advertising rules, Heinz had no input or product placement, but was named as the show's sponsor. "This is about creating a high level of quality. The only risk would be if the consumer felt he's being fed a commercial," says Anna Prosser...

Author: /time Magazine | Title: The Stealthy Sell | 8/3/2003 | See Source »

...James Mullen and the biotechnology industry arrived on the scene together by chance in 1980. That year he landed his first job out of college, as a chemical engineer for what is now the U.K.-based pharmaceutical firm GlaxoSmithKline; at about the same time in San Francisco, Genentech, the pioneering biotech firm, sold its first shares to the public. Now Mullen, 44, and the biotech industry are coming of age together - only this time it's no accident. As the ceo of Biogen in Cambridge, Massachusetts, Mullen is helping force the issue with his proposal last month to merge...

Author: /time Magazine | Title: Will This Experiment Work? | 7/13/2003 | See Source »

...fund has cut its biotech holdings a third, and six top executives at Genentech recently sold $36 million of the stock. The relatively stodgy feel of the Biogen-IDEC deal has still other growth investors running for the hills. It's all part of growing up--and part of Mullen's plan. --With reporting by Eric Roston/Washington and Unmesh Kher and Barbara Kiviat/New York

Author: /time Magazine | Title: Will This Experiment Work? | 7/7/2003 | See Source »

Previous | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | Next